The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

The Drug Discovery and Development program provides in-depth exposure to the multiple elements involved in the discovery and development of marketed drugs. It provides the rigorous scientific and ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...